PRAH
NASDAQPRA Health Sciences, Inc.
PRA Health Sciences, Inc. (PRAH) is a Biotechnology: Commercial Physical & Biological Resarch company listed on NASDAQ. There were no new wire items for PRAH in the last 30 days. The most recent was published Mar 3, 2025.
Latest news
25 items- PRKent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix BoardBelieves Incumbent Board's Approval and Ongoing Pursuit of Reckless and Dilutive Proposed Merger with Akoya Biosciences Demonstrates Urgent Need for Refreshment Nominees Would Bring Deep Healthcare and Financial Experience Necessary to Properly Oversee a Standalone Quanterix, Prevent Further Capital Misallocation and Improve Shareholder Value Kent Lake Urges Shareholders to Vote Against Merger with Akoya to Protect the Future Value of Their Investment Kent Lake PR LLC ("Kent Lake"), a holder of 6.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), announced today it has nominated three highly qualified, independent candidates for e
- 13D/GSEC Form SC 13G filed by PRA Health Sciences, Inc.SC 13G - PRA Health Sciences, Inc. (0001613859) (Subject)
- 13D/GSEC Form SC 13G/A filed by PRA Health Sciences, Inc. (Amendment)SC 13G/A - PRA Health Sciences, Inc. (0001613859) (Subject)
- INSIDERSEC Form 4: Gaenzle Christopher L returned 34,500 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: SHANNON COLIN returned 46,500 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: Bonello Michael J. returned 4,480 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: Young Matthew P. returned 7,127 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: Stettin Glen D. returned 1,049 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: MOMTAZEE JAMES C returned 3,521 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: Dickinson Alexander George returned 5,407 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: Grais Linda returned 9,683 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: Barber Jeffrey T returned 14,729 units of Common Stock to the company, closing all direct ownership in the company4 - PRA Health Sciences, Inc. (0001613859) (Issuer)
- SECSEC Form S-8 POS filed by PRA Health Sciences, Inc.S-8 POS - PRA Health Sciences, Inc. (0001613859) (Filer)
- SECSEC Form S-8 POS filed by PRA Health Sciences, Inc.S-8 POS - PRA Health Sciences, Inc. (0001613859) (Filer)
- SECSEC Form S-8 POS filed by PRA Health Sciences, Inc.S-8 POS - PRA Health Sciences, Inc. (0001613859) (Filer)
- SECSEC Form S-8 POS filed by PRA Health Sciences, Inc.S-8 POS - PRA Health Sciences, Inc. (0001613859) (Filer)
- SECSEC Form POSASR filed by PRA Health Sciences, Inc.POSASR - PRA Health Sciences, Inc. (0001613859) (Filer)
- SECSEC Form 25-NSE filed by PRA Health Sciences, Inc.25-NSE - PRA Health Sciences, Inc. (0001613859) (Subject)
- SECPRA Health Sciences, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits8-K - PRA Health Sciences, Inc. (0001613859) (Filer)
- SECPRA Health Sciences, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - PRA Health Sciences, Inc. (0001613859) (Filer)
- INSIDERSEC Form 4: Bonello Michael J. sold $1,229,886 worth of Common Stock (7,384 units at $166.56), decreasing direct ownership by 62% to 4,480 units (Amendment)4/A - PRA Health Sciences, Inc. (0001613859) (Issuer)
- INSIDERSEC Form 4: SHANNON COLIN sold $1,353,611 worth of Common Stock (8,126 units at $166.58), decreasing direct ownership by 15% to 46,500 units (Amendment)4/A - PRA Health Sciences, Inc. (0001613859) (Issuer)
- PRDT Midstream Set to Join S&P MidCap 400NEW YORK, June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE:DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective prior to the open on Friday, July 2. ICON plc (NASD: ICLR) is acquiring PRA Health Sciences in a deal expected to be completed soon pending final closing conditions. S&P 500 constituent DTE Energy Co. (NYSE:DTE) is spinning off DT Midstream in a transaction expected to be effective prior to the open on Thursday, July 1. Post spin-off, DTE Energy will remain in the S&P 500. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker
- SECPRA Health Sciences, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - PRA Health Sciences, Inc. (0001613859) (Filer)
- PRVeradigm and PRA Health Sciences Partner to Create the Industry's Leading EHR-Based Clinical Research NetworkThrough this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients' access to clinical research Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ:MDRX), and PRA Health Sciences, Inc. (NASDAQ:PRAH), one of the world's leading global contract research organizations, announced today the creation of the industry's leading electronic healthcare records-based clinical research network that reaches more than 25,000 physicians and 40 million patients across the United States. This press re
PRAH FAQ
6 questionsWhat is the latest news on PRAH?
Quantisnow has not tracked any new filings, ratings or press releases for PRAH in the last 30 days. The most recent wire item was published on March 3, 2025.Where does PRAH stock trade?
PRA Health Sciences, Inc. (PRAH) is listed on NASDAQ.What sector and industry is PRAH in?
PRA Health Sciences, Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did PRA Health Sciences, Inc. go public?
PRA Health Sciences, Inc. (PRAH) completed its IPO in 2014.What companies are similar to PRAH?
Notable peers in the same industry include INCY (Incyte Corp.), CRL (Charles River Laboratories International Inc.), ABSI (Absci Corporation), NRC (NRC Health), ICLR (ICON plc). Compare PRAH side-by-side with any of them on Quantisnow.How can I track PRAH on Quantisnow?
Quantisnow aggregates PRA Health Sciences, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRAH to receive live email and push alerts on every new disclosure.